If You Like Illumina, You'll Love Genomic Health – Seeking Alpha

If You Like Illumina, You'll Love Genomic Health
Seeking Alpha
When most investors think of a genome sequencing stock, they think of Illumina (ILMN). And well they should. With a market cap of $27 billion, it's one of the biggest in the still-nascent business, and is arguably the most recognizable name in the …

and more »

Source: Genome Sequencing